Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

NCT00660387 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Parkinson's Disease

Interventions

DRUG: Levodopa carbidopa intestinal gel (LCIG)
DRUG: Placebo Gel
DRUG: Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets
DRUG: Placebo (PBO) oral capsules
DEVICE: CADD-Legacy® 1400 ambulatory infusion pump
DEVICE: PEG tube
DEVICE: J-tube

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]